80 related articles for article (PubMed ID: 113015)
1. Toxicity studies on lidamidine hydrochloride (WHR-1142A), a novel antidiarrheal agent.
Chou BJ; Mir GN; Brown WR; Rapp WR; Yelnosky J
Arzneimittelforschung; 1978; 28(8a):1471-6. PubMed ID: 113015
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological properties of lidamidine hydrochloride (WHR-1142A), a novel antidiarrheal agent.
Mir GN; Sperow JW; Riley RL; Alioto RL; Nuss GW; Chou BJ; Yelnosky J
Arzneimittelforschung; 1978; 28(8a):1466-70. PubMed ID: 582538
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and disposition of lidamidine hydrochloride (WHR-1142A), a novel antidiarrheal agent, in rat and monkey.
DeLong AF; Martin GP; Polk A; Carter V; Herczeg T
Arzneimittelforschung; 1978; 28(8a):1477-80. PubMed ID: 113016
[TBL] [Abstract][Full Text] [Related]
4. In vivo antimotility and antidiarrheal activity of lidamidine hydrochloride (WHR-1142A), a novel antidiarrheal agent. Comparison with diphenoxylate and loperamide.
Mir GN; Alioto RL; Sperow JW; Eash JR; Krebs JB; Yelnosky J
Arzneimittelforschung; 1978; 28(8a):1448-54. PubMed ID: 582536
[TBL] [Abstract][Full Text] [Related]
5. Effects of lidamidine hydrochloride (WHR-1142A), a novel antidiarrheal agent on the cardiovascular and central nervous systems.
Riley RL; Mir GN; Rowles GS; Sperow JW; Alioto RL; Yelnosky J
Arzneimittelforschung; 1978; 28(8a):1461-6. PubMed ID: 582537
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of action studies of lidamidine hydrochloride (WHR-1142A), a novel antidiarrheal agent.
Mir GN; Sperow JW; Krebs JB; Eash JR; Rowles GS; Yelnosky J
Arzneimittelforschung; 1978; 28(8a):1454-61. PubMed ID: 89850
[TBL] [Abstract][Full Text] [Related]
7. Analytical-physical profile of lidamidine hydrochloride (WHR-1142A), a novel antidiarrheal agent.
Zalipsky JJ; Won CM; Patel DM
Arzneimittelforschung; 1978; 28(8a):1441-7. PubMed ID: 582535
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of the safety and effectiveness of WHR-1142A in the treatment of non-specific acute diarrhea].
Heredia Díaz JG; Alcántara I; Solís A
Rev Gastroenterol Mex; 1979; 44(4):167-73. PubMed ID: 394268
[TBL] [Abstract][Full Text] [Related]
9. WHR 1049, a potent metabolite of lidamidine, has antidiarrheal and antimotility effects on the small intestine in rats.
Eaker EY; Bixler GB; Mathias JR
J Pharmacol Exp Ther; 1988 Aug; 246(2):786-9. PubMed ID: 3404458
[TBL] [Abstract][Full Text] [Related]
10. Loperamide (R 18 553), a novel type of antidiarrheal agent. Part 1: in vivo oral pharmacology and acute toxicity. Comparison with morphine, codeine, diphenoxylate and difenoxine.
Niemegeers CJ; Lenaerts FM; Janssen PA
Arzneimittelforschung; 1974 Oct; 24(10):1633-6. PubMed ID: 4479775
[No Abstract] [Full Text] [Related]
11. An evaluation of the toxicity of cefaclor in laboratory animals.
Hanasono GK; Owen NV; Gibson WR; Hoffman DG; Morton DM
Postgrad Med J; 1979; 55 Suppl 4():17-21. PubMed ID: 121454
[TBL] [Abstract][Full Text] [Related]
12. NTP Toxicology and Carcinogenesis Studies of Promethazine Hydrochloride (CAS No. 58-33-3) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Dec; 425():1-272. PubMed ID: 12616286
[TBL] [Abstract][Full Text] [Related]
13. A multicenter double-blind controlled trial comparing lidamidine HCl and loperamide in the symptomatic treatment of acute diarrhoea.
Gasbarrini G; Corazza GR; Feliciani M; Albano O; Stufano N; Altomare E; Fontana G; Valpiani D; Chiodo F; Banterle C
Arzneimittelforschung; 1986 Dec; 36(12):1843-5. PubMed ID: 3551969
[TBL] [Abstract][Full Text] [Related]
14. Loperamide (R 18 553), a novel type of antidiarrheal agent. Part 4: studies on subacute and chronic toxicity and the effect on reproductive processes in rats, dogs and rabbits.
Marsboom R; Hérin V; Verstraeten A; Vandesteene R; Fransen J
Arzneimittelforschung; 1974 Oct; 24(10):1645-9. PubMed ID: 4479778
[No Abstract] [Full Text] [Related]
15. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
16. Antimotility and antisecretory activity of some aryl substituted amidinoureas.
Douglas GH; Diamond J; Studt WL; Mir GN; Alioto RL; Auyang K; Burns BJ; Cias J; Darkes PR; Dodson SA; O'Connor S; Santora NJ; Tsuei CT; Zalipsky JJ; Zimmerman HK
Arzneimittelforschung; 1978; 28(8a):1435-41. PubMed ID: 582534
[TBL] [Abstract][Full Text] [Related]
17. NTP technical report on the toxicity studies of methacrylonitrile (CAS No. 126-98-7). Administered by gavage to F344/N rats and B6C3F1 mice.
Ghanayem BI
Toxic Rep Ser; 2000 May; (47):1-56, A1-E6. PubMed ID: 11803706
[TBL] [Abstract][Full Text] [Related]
18. Acute and subacute toxicity of 2,6-dimethyl-3,5-dimethoxycarbonyl-4-(o-difluoromethoxyphenyl)-1 ,4-dihydropyridine (PP-1466).
Gomi T; Yamamoto H; Ozeki M; Fujikura M; Hirao A; Kobayashi M; Tateishi T; Yumoto S; Okumura M; Aikawa K
Arzneimittelforschung; 1985; 35(6):915-22. PubMed ID: 4026916
[TBL] [Abstract][Full Text] [Related]
19. Pre-clinical toxicity studies on the new nitroimidazole 1-methylsulphonyl-3-(1-methyl-5-nitroimidazole-2-yl)-2- imidazolidinone.
Rao RR; Nair TB; Marathe MR; Gangoli SD
Arzneimittelforschung; 1985; 35(11):1692-6. PubMed ID: 4091872
[TBL] [Abstract][Full Text] [Related]
20. NTP Toxicology and Carcinogenesis Studies of Dimethyl Methylphosphonate (CAS No. 756-79-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1987 Nov; 323():1-172. PubMed ID: 12748730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
